首页|UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP
UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
万方数据
维普
Uveal melanoma(UM)poses a significant lethality,with approximately 50%of those developing metastases surviving less than one year.In the progression of UM,vasculogenic mimicry(VM)induced by hypoxia plays a pivotal role,which also partially explains the resistance of UM to anti-angiogenic therapies.Nevertheless,the crucial molecular mechanisms underlying VM in the progres-sion of UM remain unclear.We identified ubiquitin conjugating enzyme E2 G2(UBE2G2)as a critical suppressor through transcriptomic sequencing and metastasis correlation screening.In UM,hypoxia-induced VM and metastasis are markedly exacerbated by UBE2G2 knockdown and significantly allevi-ated by its overexpression.Mechanistically,UBE2G2 directly binds to galectin 3 binding protein(LGALS3BP)and forms a complex with the E3 ubiquitin ligase tripartite motif containing 38(TRIM38),facilitating ubiquitination-mediated degradation of LGALS3BP at the K104 residue.Further-more,UBE2G2 inhibits oncogenic phenotypes by inactivating intracellular PI3K/AKT signaling and re-programming the tumor microenvironment.Therefore,targeting intercellular and intracellular molecular mechanisms of the hypoxia-UBE2G2-LGALS3BP axis may contribute to developing various therapeu-tic strategies for UM.
UBE2G2Vasculogenic mimicryInvasion and metastasisUveal melanomaUbiquitinationTumor microenvironmentLGALS3BPHypoxia